Search Results Search Sort by RelevanceMost Recent Viewpoint Nov 1999 The Value of Industry Gifts to Physicians Audiey Kao, MD, PhD Virtual Mentor. 1999;1(3):21-22. doi: 10.1001/virtualmentor.1999.1.3.dykn1-9911. Case and Commentary Dec 1999 Disclosing the Truth about Medical Error Audiey Kao, MD, PhD Virtual Mentor. 1999;1(4):26-27. doi: 10.1001/virtualmentor.1999.1.4.hlaw1-9912. Case and Commentary Feb 2013 Quality Improvement of Economic Profiling Marguerite Huff Virtual Mentor. 2013;125-130. doi: 10.1001/virtualmentor.2013.15.2.bndr2-1302. Case and Commentary Aug 2016 Is Consent to Autopsy Necessary? Cartesian Dualism in Medicine and Its Limitations Megan Lane and Christian J. Vercler, MD, MA The authors address the medical ethics question of whether autopsy is necessary from Cartesian and sociocultural perspectives and how to obtain consent. AMA J Ethics. 2016;18(8):771-778. doi: 10.1001/journalofethics.2016.18.8.ecas2-1608. Case and Commentary Nov 2016 Requests for VIP Treatment in Pathology: Implications for Social Justice and Systems-Based Practice Virginia Sheffield and Lauren B. Smith, MD Preferential treatment of “very important” patients is not only unjust but also can compromise patient safety, which is overlooked in medical ethics. AMA J Ethics. 2016;18(8):786-792. doi: 10.1001/journalofethics.2016.18.8.ecas4-1608. AMA Code Says Jul 2003 The Code on Physicians' Relationship with Industry Audiey C. Kao, MD, PhD Virtual Mentor. 2003;5(7):263-264. doi: 10.1001/virtualmentor.2003.5.7.code1-0307. Personal Narrative Jul 2003 The Twelve Days of Christmas Audiey C. Kao, MD, PhD Virtual Mentor. 2003;5(7):281-282. doi: 10.1001/virtualmentor.2003.5.7.mhum1-0307. Case and Commentary Jul 2003 Drug Company Sponsorship of Clinical Conferences, Commentary 1 Robert Goodman, MD Virtual Mentor. 2003;5(7):239-241. doi: 10.1001/virtualmentor.2003.5.7.ccas1-0307. Case and Commentary Jul 2003 Drug Company Sponsorship of Clinical Conferences, Commentary 2 Ashley Wazana, MD Virtual Mentor. 2003;5(7):242-246. doi: 10.1001/virtualmentor.2003.5.7.ccas1-0307. Case and Commentary Jul 2003 Clinician and Researcher, Commentary 1 Timothy F. Murphy, PhD Virtual Mentor. 2003;5(7):247-250. doi: 10.1001/virtualmentor.2003.5.7.ccas2-0307. Pagination First page « First Previous page ‹ Previous … Page 6 Page 7 Page 8 Page 9 Current page 10 Page 11 Page 12 Page 13 Page 14 … Next page Next › Last page Last »
Viewpoint Nov 1999 The Value of Industry Gifts to Physicians Audiey Kao, MD, PhD Virtual Mentor. 1999;1(3):21-22. doi: 10.1001/virtualmentor.1999.1.3.dykn1-9911.
Case and Commentary Dec 1999 Disclosing the Truth about Medical Error Audiey Kao, MD, PhD Virtual Mentor. 1999;1(4):26-27. doi: 10.1001/virtualmentor.1999.1.4.hlaw1-9912.
Case and Commentary Feb 2013 Quality Improvement of Economic Profiling Marguerite Huff Virtual Mentor. 2013;125-130. doi: 10.1001/virtualmentor.2013.15.2.bndr2-1302.
Case and Commentary Aug 2016 Is Consent to Autopsy Necessary? Cartesian Dualism in Medicine and Its Limitations Megan Lane and Christian J. Vercler, MD, MA The authors address the medical ethics question of whether autopsy is necessary from Cartesian and sociocultural perspectives and how to obtain consent. AMA J Ethics. 2016;18(8):771-778. doi: 10.1001/journalofethics.2016.18.8.ecas2-1608.
Case and Commentary Nov 2016 Requests for VIP Treatment in Pathology: Implications for Social Justice and Systems-Based Practice Virginia Sheffield and Lauren B. Smith, MD Preferential treatment of “very important” patients is not only unjust but also can compromise patient safety, which is overlooked in medical ethics. AMA J Ethics. 2016;18(8):786-792. doi: 10.1001/journalofethics.2016.18.8.ecas4-1608.
AMA Code Says Jul 2003 The Code on Physicians' Relationship with Industry Audiey C. Kao, MD, PhD Virtual Mentor. 2003;5(7):263-264. doi: 10.1001/virtualmentor.2003.5.7.code1-0307.
Personal Narrative Jul 2003 The Twelve Days of Christmas Audiey C. Kao, MD, PhD Virtual Mentor. 2003;5(7):281-282. doi: 10.1001/virtualmentor.2003.5.7.mhum1-0307.
Case and Commentary Jul 2003 Drug Company Sponsorship of Clinical Conferences, Commentary 1 Robert Goodman, MD Virtual Mentor. 2003;5(7):239-241. doi: 10.1001/virtualmentor.2003.5.7.ccas1-0307.
Case and Commentary Jul 2003 Drug Company Sponsorship of Clinical Conferences, Commentary 2 Ashley Wazana, MD Virtual Mentor. 2003;5(7):242-246. doi: 10.1001/virtualmentor.2003.5.7.ccas1-0307.
Case and Commentary Jul 2003 Clinician and Researcher, Commentary 1 Timothy F. Murphy, PhD Virtual Mentor. 2003;5(7):247-250. doi: 10.1001/virtualmentor.2003.5.7.ccas2-0307.